GAM Holding’s AMAG Pharmaceuticals AMAG Stock Holding History

GAM Holding’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-48,300	Closed	-$1.92M	–	1164
2015 Q3	$1.92M	Buy	+48,300	New	+$3M	0.03%	504

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GAM Holding's AMAG Position: Q4 2015 in Review

GAM Holding sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 48,300 shares — an estimated $1.92M sold.

GAM Holding first reported a position in AMAG in Q3 2015 and held it in 1 quarter. The position peaked at $1.92M in Q3 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

GAM Holding reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
GAM Holding sold 48,300 AMAG Pharmaceuticals shares in Q4 2015, an estimated $1.92M.
GAM Holding first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 1 quarter.
GAM Holding's AMAG Pharmaceuticals position peaked at $1.92M in Q3 2015.
172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on GAM Holding's 13F filing for Q4 2015, filed 8 Feb 2016.